Synthesis and antitumor activity of cyclopentane-fused anthraquinone derivatives-Reference-Cited by-同舟云学术

Synthesis and antitumor activity of cyclopentane-fused anthraquinone derivatives

Published:2024-02 Issue: Volume:265 Page:116103
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Tikhomirov Alexander S.,Sinkevich Yuri B.,Dezhenkova Lyubov G.,Kaluzhny Dmitry N.,Ilyinsky Nikolay S.,Borshchevskiy Valentin I.,Schols Dominique,Shchekotikhin Andrey E.^ORCID

Funder

Ministry of Science and Higher Education of the Russian Federation

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference31 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. An overview of doxorubicin formulations in cancer therapy;Rivankar;J. Cancer Res. Therapeut.,2014

3. Is there scope for better individualisation of anthracycline cancer chemotherapy?;Sallustio;Br. J. Clin. Pharmacol.,2020

4. Light-activated cytotoxicity studies on Co(II) complexes having tridentate anthraquinone-based ligands;Das;Inorg. Chim. Acta.,2023

5. Heterocyclic ring expansion yields anthraquinone derivatives potent against multidrug resistant tumor cells;Tikhomirov;Bioorg. Chem.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic resistance challenge: evaluating anthraquinones as rifampicin monooxygenase inhibitors through integrated bioinformatics analysis;Genomics & Informatics;2024-09-04

2. Discovery of new tricyclic spiroindole derivatives as potent P-glycoprotein inhibitors for reversing multidrug resistance enabled by a synthetic methodology-based library;RSC Medicinal Chemistry;2024